Isolation of isoxanthanol and synthesis of novel derivatives as potential cytotoxic agents
- 121 Downloads
Novel synthetic derivatives of sesquiterpene lactone isoxanthanol (1) have been prepared and bioevaluated against four human cancer cell lines viz. T98G (glioblastoma), A431 (epidermoid carcinoma), NCI-H322 (bronchioloalveolar carcinoma), and A549 (lung adeno carcinoma) for their cytotoxic potential using paclitaxel as the standard. This has resulted in the identification of potent molecules displaying IC50 1.9 and 5.0 µM, respectively against the A549 cancer cell line. The study has resulted in the identification of potential cytotoxic activity of the analog (compound 10) bearing electron donating aryl alkenoic substituent. Furthermore, the induction of cell death has been assessed for the most active compound (10) using flow cytometric method and sub-G1 cell population determination by propidium iodide staining. The concentration dependent inhibitory effect of 10 on the A549 cells ability did not reproduce and form colonies at 20 µM concentration.
Synthesis of isoxanthanol derivatives and their cytotoxic study resulted in identification of potential cytotoxic agents. Compound 10, one of its aryl alkenoic substituent showed potency against NCI-H322 (bronchioloalveolar carcinoma), and A549 (lung adeno carcinoma) cell lines.
KeywordsIsoxanthanol Sesquiterpene Lactone Human leukemia
New chemical entities
Food and drugs administration
High resolution mass spectra
Phosphate buffer saline
N,N-dimethyl amino pyridine
The CSIR is well acknowledged for financial support under 12th five-year project BSC0108. The authors thank Botany division of the Institute for providing the plant material, Instrumentation division for spectral data, and CSIR-UGC for the award of Fellowship to one of the author (PKC). IIIM publication no. IIIM/2011/2017.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Yoon JH, Lim HJ, Lee HJ, Kim HD, Jeon R, Ryu J-H (2008) Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor. Bioorg Med Chem Lett 18:2179–2185CrossRefPubMedGoogle Scholar
- Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, Shi Y, Jia Y, Han B, Zhang W, Qui C, Ma X, Li Q, Shi Q, Zhang H, Li D, Zhang J, Lin J, Li L, Gao Y, Chen Y (2012) Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem 55:8757–8769CrossRefPubMedGoogle Scholar